Background and Key Drivers Leading to Clinical Immunogenicity
Dr Matthew Baker, Chief Scientific Officer at Antitope Ltd, speaking at Bioprocessing, Biologics and Biotherapeutics 2011.
The Potential of High Content Imaging in Primary Screening
Daniela Siebert, Novartis, speaking at Screening Europe 2011
Challenges for High Content Analysis of Infectious Diseases
Anne Danckaert, Institut Pasteur, speaking at Screening Europe 2011
Modeling and Prediction of Antibody Chromatography Purification
Professor Christian Frech, Mannheim University of Applied Science, speaking at BioProcessing, Biologics and Biotherapeutics Congress.
A Systematic Investigation of Candidate Breast Cancer Progression-Associated Biomarkers Identified from Omic Screens: Leveraging Antibody-Based Proteomics
Prof. William Gallagher, Chief Scientific Officer at OncoMark, speaking at Advances in Microarray Technology 2011.
A High Quality High Content Screening Assay for Intracellular Leishmania
Manu De Rycker, University of Dundee, speaking at Screening Europe 2011
High Content Screening for Cytoskeletal Rearrangements
María Montoya, Centro Nacional de Investigaciones Cardiovasculares, speaking at Screening Europe 2011
Kinetic Monitoring of Cellular cAMP/cGMP Signalling
Reinhard Seifert, Sibion Biosciences, speaking at Screening Europe 2011
From Acquisition to Analysis: Tools to Improve the High Content Screening Workflow for Stem Cell Assays
Ben Haworth, Molecular Devices, speaking at Screening Europe 2011.